Drug Reverses Hair Loss Caused By Radiation For Brain, Head, Neck Cancers
- byDoctor News Daily Team
- 29 July, 2025
- 0 Comments
- 0 Mins
Treatment with topical minoxidil helps restore hair loss caused by radiation treatment for brain tumors and other head and neck cancers, a study published Wednesday by JAMA Dermatology found.
Twenty-eight of 34 patients treated with the drug after radiation therapy experienced hair regrowth in as little as three weeks, researchers said.
Minoxidil is an over-the-counter medication approved by the U.S. Food and Drug Administration for hair regrowth in men and women.
The patients suffered from persistent radiation-induced alopecia, or hair loss, as a result of cancer treatment, the researchers said.
The hair loss from radiation is "a dose-dependent phenomenon," and was linked specifically to higher doses of radiation applied to the scalp, researchers at Memorial Sloan-Kettering Cancer Center in New York said.
In addition, the radiation therapy was associated with a six-fold increase in the risk for hair loss, the researchers said.
Although this kind of hair loss varies in severity and duration, it can be particularly pronounced in patients who undergo treatment for brain tumors, spinal tumors and head and neck cancers, such as throat cancer, because radiation often targets the area on or near the scalp, according to the study authors.
In the study, researchers evaluated 70 patients who ranged from age 4 to 75, who had either a central nervous system tumor or a form of head and neck cancer.
Forty of the 70 patients had moderate, or grade 1, hair loss, while 29 had evidence of "localized" -- confined to the area treated with radiation -- hair loss and 25 showed diffuse or mixed hair loss patterns, the researchers said.
In addition to the successful treatment with minoxidil, two patients responded well to hair transplantation and one patient responded well to plastic surgical scalp reconstruction, researchers said.
"These findings may inform pre-therapy counseling and efforts to identify preventive and therapeutic strategies, including randomized clinical trials in cancer survivors, for this burdensome [complication]," the authors wrote.
For more details click on the link: doi:10.1001/jamadermatol.2020.2127
Disclaimer: This website is designed for healthcare professionals and serves solely for informational purposes.
The content provided should not be interpreted as medical advice, diagnosis, treatment recommendations, prescriptions, or endorsements of specific medical practices. It is not a replacement for professional medical consultation or the expertise of a licensed healthcare provider.
Given the ever-evolving nature of medical science, we strive to keep our information accurate and up to date. However, we do not guarantee the completeness or accuracy of the content.
If you come across any inconsistencies, please reach out to us at
admin@doctornewsdaily.com.
We do not support or endorse medical opinions, treatments, or recommendations that contradict the advice of qualified healthcare professionals.
By using this website, you agree to our
Terms of Use,
Privacy Policy, and
Advertisement Policy.
For further details, please review our
Full Disclaimer.
Recent News
Eli Lilly plans to build new USD 3 billion facilit...
- 04 November, 2025
Rajkot Maternity Hospital CCTV Leak: How a simple...
- 04 November, 2025
Gland Pharma profit rises 12 percent to Rs 184 cro...
- 04 November, 2025
Daily Newsletter
Get all the top stories from Blogs to keep track.
0 Comments
Post a comment
No comments yet. Be the first to comment!